GlassScriptPhysician profile
Ravi Bharat Patel
NPI 1275896482
$3,547.07
in general payments reported to CMS, 2019-2025
11 companies · $2,895 in 2025
The $2,895 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.01 · 2022: $28.02 · 2023: $299 · 2024: $294 · 2025: $2,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,800 · Food and Beverage: $431 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,800.00 |
| Food and Beverage | $431.38 |
| Travel and Lodging | $257.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $2,800.00 | 2025 | Mounjaro |
| Stryker Corporation | $415.20 | 2023-2024 | Blueprint Patient Specific Instrumentation |
| Zest Holdings, LLC | $92.03 | 2024-2025 | |
| Boston Scientific Corporation | $57.92 | 2024 | Solyx Sis System, Watchman Flx |
| Shockwave Medical, INC | $41.73 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ge Healthcare | $35.04 | 2025 | |
| Allergan, INC. | $30.01 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.61 | 2025 | |
| Heartflow, INC. | $21.51 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.